0001562180-24-005547.txt : 20240702 0001562180-24-005547.hdr.sgml : 20240702 20240702183639 ACCESSION NUMBER: 0001562180-24-005547 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240702 DATE AS OF CHANGE: 20240702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KINDLER JEFFREY B CENTRAL INDEX KEY: 0001174454 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39926 FILM NUMBER: 241097598 MAIL ADDRESS: STREET 1: 35 E. 62ND ST CITY: NEW YORK STATE: NY ZIP: 10065 FORMER NAME: FORMER CONFORMED NAME: Kindler Jeffrey B. DATE OF NAME CHANGE: 20150730 FORMER NAME: FORMER CONFORMED NAME: KINDLER JEFFREY B DATE OF NAME CHANGE: 20020529 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Terns Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001831363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-525-5535 EXT.101 MAIL ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-07-01 false 0001831363 Terns Pharmaceuticals, Inc. TERN 0001174454 KINDLER JEFFREY B C/O TERNS PHARMACEUTICALS, INC. 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 true false false false false Stock Option (Right to Buy) 6.85 2024-07-01 4 A false 4676.00 0.00 A 2034-06-30 Common Stock 4676.00 4676.00 D This option was issued pursuant to the Issuer's Non-Employee Director Compensation Policy, under which the Reporting Person elected to receive this option in lieu of the Reporting Person's cash retainer fee of $20,000 for the third and fourth quarters of 2024. The option will vest as to 1/6th of the total shares subject thereto on each monthly anniversary of the date of grant, such that 100% of the shares subject to the option will be fully vested on January 1, 2025. /s/ Bryan Yoon as Attorney-in-Fact for Jeffrey B Kindler 2024-07-02